Article Information
History
- March 8, 2023.
Article Versions
- Version 1 (March 7, 2023 - 10:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anushka Walia, BS1,
- Alyson Haslam, PhD2,*,
- Jordan Tuia, BA2,
- Milos Milijković, MD3 and
- Vinay Prasad, MD, MPH2
- 1School of Medicine, University of California San Francisco, San Francisco, California
- 2Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
- 3Cartesian Therapeutics, Gaithersburg, Maryland
- ↵*Corresponding author:
Alyson Haslam, PhD, Department of Epidemiology and Biostatistics, UCSF Mission Bay Campus | Mission Hall: Global Health & Clinical Sciences Building | 550 16th St, 2nd Fl, San Francisco, CA 94158, Email: alyson.haslam{at}ucsf.edu, Phone: 706.206.7653